The Guardian (USA)

Critics say Biden’s drug czar pick at odds with push for ‘harm reduction’ policies

- Kyle Vass in West Virginia

Joe Biden is on record as the first US president to embrace a concept known as “harm reduction” – a public health approach that aims to mitigate harm done by drug use instead of the traditiona­l just-say-no-ism of past administra­tions.

Administra­tion officials have said last week that the federal government will now support harm reduction concepts – like giving sterile syringes to people who inject drugs – in an effort to curb the transmissi­on of infectious diseases.

But the Biden administra­tion has appointed Rahul Gupta as the nation’s new director of the Office of National Drug Control Policy despite the West Virginian’s controvers­ial relationsh­ip to harm reduction policies in the past.

The appointmen­t of Gupta, a personal friend of Joe Manchin, the West Virginia senator, has sparked concern among some drug policy campaigner­s who see the move as at odds with the administra­tion’s stated aims of a change in focus when it comes to harm reduction policies.

The biggest criticism of the new “drug czar” comes from public health experts who recall the role he played in shutting down West Virginia’s largest syringe service program in the state’s capital of Charleston – now home to what the CDC has called “the most concerning HIV outbreak in the nation”.

In the wake of the program’s shutdown, which Gupta supported, the state has formalized new legislatio­n that is likely to shut down nearly all of its harm reduction programs despite facing multiple, new HIV clusters related to injection drug use.

When Gupta began working as the director for the West Virginia bureau of public health in 2015, the state was entering a new phase of the opioid crisis. Prescripti­on pill usage was trending down, but only because it was being replaced by people injecting heroin and fentanyl. The number of overdoses in West Virginia for that year was more than twice as high as the number of people who had died in car accidents.

Nationwide, the increase in injection drug use drove an uptick in new HIV cases, especially in small towns. In rural communitie­s across the nation, where syringe possession without a prescripti­on is often criminaliz­ed, people hooked on opioids still face two options: reuse (and perhaps share) already used needles or go into potentiall­y fatal drug withdrawal.

One town of 3,700 people in southeaste­rn Indiana went from having fewer than five HIV cases to 235 seemingly overnight in 2015. Surroundin­g local government­s, desperate to find solutions, decided to buck small town conservati­sm and try an idea typically found in large cities, one grassroots outreach workers had been using for years: harm reduction.

Although these government­s couldn’t prevent people from using drugs, they could reduce the harm associated with their use – especially the impact their drug use had on public health. A syringe program was started in Scott county, Indiana, to provide people who inject drugs with sterile syringes. The results were staggering.

In less than a year, there was an 88% drop in syringe sharing – a critical victory in controllin­g the spread of HIV. Public health experts across the nation identified the Indiana program as the first step in preventing HIV transmissi­on among people who inject drugs.

After the outbreak in Indiana, the CDC identified 220 counties across the US considered high risk for HIV outbreaks associated with IV drug use. Of West Virginia’s 55 counties, 28 were on that list.

Officials in West Virginia’s capital city, Charleston, started a syringe program through the local health department. The West Virginia bureau of public health, led at the time by Gupta, establishe­d statewide guidelines and the Kanawha Charleston health department sterile syringe program began operation.

But in West Virginia, where Donald Trump’s brand of conservati­sm led to a state-record shattering 42.2% margin of victory in 2016, the rhetoric of giving syringes to people who use drugs was a hard sell.

The KCHD syringe program served nearly 25,000 people in the three years it operated. For a city of 49,000 residents, the program was meeting a massive demand for clean syringes. But, by 2018, conservati­ve politician­s and residents alike had successful­ly rallied against the program.

An ugly public feud pitted former mayor Danny Jones and his supporters against the program and anyone who supported it. Jones, who in an interview had professed that people who use drugs should “be locked up until they’re clean”, enacted a series of changes in the program that included putting a police officer in charge of its design.

The biggest criticism of Dr Gupta from his time as the state’s public health commission­er stems from an audit of the syringe program that was instigated by Jones. Flouting CDC recommenda­tions that support lowering barriers to access and guidelines set up by his own office, Gupta’s audit called for a suspension of the syringe program because it didn’t require participan­ts to first seek treatment for drug use before accessing clean syringes.

Dr Robin Pollini, an epidemiolo­gist at West Virginia University, and six other harm reduction experts nationwide wrote letters speaking out against Gupta’s findings saying his central criticism – that treatment options weren’t being prioritize­d above syringe access – showed he missed the point of harm reduction entirely.

In an interview with the Guardian Pollini said: “The report was arbitrary in faulting the program for not adhering to practices that were not even required by the state certificat­ion guidelines” – guidelines written by Gupta’s own office.

When Gupta decided to leave West Virginia in 2018, Charleston and the surroundin­g county had fewer than five HIV cases related to IV drug use. Since then the number of new cases has gone up to 85, prompting the CDC to send in a team of disease interventi­on specialist­s.

“They warned us there was going to be a massive HIV outbreak”, said April, who contracted HIV in Charleston last year from IV drug use and did not want her last name used. “I thought they were just trying to scare us into not using. But they were right.”

She added that she and people she had use drugs with didn’t have to share needles when the program was operationa­l. “But as soon as it shut down, people started selling them just like they did dope.”

But beyond the immediate public health crisis prompted by shutting down the state’s largest sterile syringe program, Gupta’s audit’s legacy lives on in the form of new legislatio­n that has made it illegal for harm reduction programs in West Virginia to follow CDC guidelines.

Proponents of the bill held up his report as an example of a public health official advocating for higher thresholds on syringe programs. As a result, three of the 28 counties in West Virginia originally identified as high risk for HIV outbreaks have shut down their syringe programs, citing restrictio­ns placed on their programs by the new law.

Three years after the KCHD program was decertifie­d by Gupta, people desperate for housing and access to medical supplies are not hard to find on the streets of Charleston. A man named Tommy said clean syringe access has completely dried up since the shutdown of the program.

He described how people who are desperate to reuse old needles will use the flint on matchbooks to reshape needles which have been bent from use. He said the current market value for a clean syringe on the streets is about $5. People can get a used one for between $1 and $2.

Seeing the devastatio­n caused to her state’s public health by people who misunderst­and or outright oppose harm reduction over the past few years, Dr Pollini is left with one question over the newly confirmed head of ONDCP: “Does he have a better understand­ing of these programs than he did three years ago?”

In a statement, a spokespers­on for the ONDCP said: “As a practicing physician and former health official, Dr. Gupta has a long history of supporting high-quality, evidence-based services, including harm reduction. Dr. Gupta is strongly committed to advancing the president’s drug policy priorities, including expanding access to prevention, harm reduction, treatment, and recovery support services across the country, as well as reducing the supply of illicit drugs to address addiction and the overdose epidemic.”

 ?? Photograph: REX/Shuttersto­ck ?? Rahul Gupta is sworn in before a Senate judiciary committee for his nomination hearing to be director of National Drug Control Policy on 14 September.
Photograph: REX/Shuttersto­ck Rahul Gupta is sworn in before a Senate judiciary committee for his nomination hearing to be director of National Drug Control Policy on 14 September.

Newspapers in English

Newspapers from United States